ripekg:evaluation/RIPEA7A26A29DA8B9E483 |
prov:used |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA7A26A29DA8B9E483 |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA7A26A29DA8B9E483 |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
ripe:concerns |
ripekg:work/10.1186%2Fs13063-020-04400-4Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
ripe:recruitmentEndDateExtractionRationale |
No explicit end-of-recruitment date after full search. |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
ripe:recruitmentStartDateExtractionRationale |
Currently, recruitment has not yet started, with the start scheduled for the second week of May 2020, but no specific date is mentioned. |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
ripe:studyEndDateExtractionRationale |
No explicit study end date found. |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA7A26A29DA8B9E483-human-2-2 |
ripekg:study-design-evidence/RIPEA7A26A29DA8B9E483 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA7A26A29DA8B9E483-inspectai-2-2 |